Two cases of a pharmacokinetic interaction between (val)acyclovir and mycophenolate mofetil
Background: Administration of (val)acyclovir in combination with mycophenolate mofetil (MMF) can result in increased acyclovir plasma levels due to competition with acyclovir for renal tubular secretion. Several studies of pharmacokinetic interactions between acyclovir and MMF have been previously d...
Main Authors: | F.A. Berger, J.E. Nagtegaal, M.M. Malingré |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-01-01
|
Series: | Clinical Infection in Practice |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2590170222000796 |
Similar Items
-
Decrease in Mycophenolate Mofetil Plasma Concentration in the Presence of Antibiotics: A Case Report in a Cystic Fibrosis Patient with Lung Transplant
by: Giuliano Ponis, et al.
Published: (2024-02-01) -
Therapeutic Drug Monitoring of Mycophenolic Acid as a Precision Medicine Tool for Heart Transplant Patients: Results of an Observational Pharmacokinetic Pilot Study
by: Francesco Lo Re, et al.
Published: (2022-06-01) -
Effect of coadministration of rifampicin on the pharmacokinetics of linezolid: clinical and animal studies
by: Satsuki Hashimoto, et al.
Published: (2018-11-01) -
Pharmacokinetics of aminoglycoside antibiotics. Based on population pharmacokinetic data determination of the loading dose, maintenance dose and dosage interval
by: Arkadiusz Gruchlik, et al.
Published: (2021-03-01) -
Population Pharmacokinetics of Valproic Acid in Pediatric and Adult Caucasian Patients
by: Paulo Teixeira-da-Silva, et al.
Published: (2022-04-01)